In silico study of the active components (17α-ethinyl estradiol and segesterone acetate) of annovera as a novel vaginal contraceptive system by docking of their binding to estrogen and progesterone receptors
- 1 February 2020
- journal article
- research article
- Published by Sami Publishing Company in Eurasian Chemical Communications
- Vol. 2 (2), 234-246
- https://doi.org/10.33945/sami/ecc.2020.2.9
Abstract
The main purpose of the present research article is docking analysis of active substances of annovera (segesterone acetate and ethinyl estradiol) with progesterone and estrogen receptors (PR and ER), respectively. The first step of this study is optimizing the title compounds using B3LYP/6-311++G(d,p) basis set of theory at room temperature in isolated form by Gaussian 03 software. The frontier molecular orbitals (FMOs) theory is used to understand the reactivity and stability of the said compounds. The global reactivity indices indicate both molecules have similar electrophilicity. After the quantum mechanical (QM) study, the docking analyses of the compounds embedded in the active sites of the receptors (PR and ER) are done using Molegro Virtual Docker (MVD) software. The docking studies show that the steric interactions play main role in ligands complex formation with the receptors.Keywords
This publication has 9 references indexed in Scilit:
- Helping patients select long-acting reversible contraceptivesJournal of the American Academy of Physician Assistants, 2019
- A New Year-Long Combination Hormonal ContraceptiveNursing for Women's Health, 2019
- Advances in contraceptive vaginal rings: what does the future hold?Expert Opinion on Pharmacotherapy, 2018
- Safety and efficacy results for the segesterone acetate ethinyl estradiol (SA/EE) contraceptive vaginal ringContraception, 2018
- Weighing the Risks and Benefits of Hormonal ContraceptionJAMA, 2018
- Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding studyContraception, 2018
- Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism StudiesEndocrinology, 2016
- A Facile Route of Synthesis for Making FlibanserinOrganic Process Research & Development, 2016
- Current status of contraceptive vaginal ringsContraception, 2013